drugset / Trial / NCT00834613
Metformin ER 750 mg Tablets, Fed
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the rate and extent of absorption of metformin from a test formulation of Metformin ER 750 mg Tablets versus the reference Glucophage® XR 750 mg Tablets under fed conditions.
Timeline
- Start
- 2003-08
- Primary completion
- 2003-08
- Completion
- 2003-08
Outcome
Met primary endpoint
registry Ratio of the T/R geometric mean x 100 103.45 (90% CI 99.87 to 107.15) NCT00834613 ↗
registry Ratio of the T/R geometric mean x 100 97.63 (90% CI 95.21 to 100.11) NCT00834613 ↗
registry Ratio of the T/R geometric mean x 100 97.63 (90% CI 95.22 to 100.1) NCT00834613 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 750 mg | — |
Indications
No indication recorded.